NasdaqCM:NAGEPersonal Products
Niagen Bioscience (NAGE) Stock Sinks As Profit Cushion Thins
Niagen Bioscience stock just absorbed a sharp reality check, closing at US$2.96, which is a 14.7% slide from the prior session. That kind of move grabs attention, yet the Q2 print itself was more muted than the chart suggests. Revenue landed at US$29.8m and net income was about US$1m, keeping the company in the black but at a much slimmer level than earlier quarters.
For investors with a longer lens, the headline is not the single quarter. It is how this thinner profitability sits against...